Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 13/20 | 0.54 |
| ▸ | MMP3 | P08254 | 12/20 | 0.54 |
| ▸ | MMP9 | P14780 | 4/20 | 0.53 |
| ▸ | MMP1 | P03956 | 3/20 | 0.53 |
| ▸ | MMP14 | P50281 | 3/20 | 0.53 |
| ▸ | MMP13 | P45452 | 4/20 | 0.40 |
| ▸ | USP5 | P45974 | 1/20 | 0.39 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.37 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6589939 | 0.92 | MMP2 (0.51) | MMP2MMP3MMP9MMP1MMP14 | |
| SCHEMBL6584427 | 0.91 | MMP2 (0.50) | MMP2MMP3MMP9MMP1MMP14 | |
| SCHEMBL6586370 | 0.91 | MMP2 (0.56) | MMP2MMP3MMP9MMP1MMP14 | |
| SCHEMBL6584479 | 0.91 | MMP2 (0.56) | MMP2MMP3MMP9MMP1MMP14 | |
| SCHEMBL6586955 | 0.90 | MMP2 (0.54) | MMP2MMP3MMP9MMP1MMP14 | |
| SCHEMBL6433864 | 0.89 | MMP2 (0.55) | MMP2MMP3MMP9MMP1MMP14 | |
| SCHEMBL6433872 | 0.89 | MMP2 (0.55) | MMP2MMP3MMP9MMP1MMP14 | |
| SCHEMBL6433867 | 0.89 | MMP2 (0.55) | MMP2MMP3MMP9MMP1MMP14 | |
| SCHEMBL6585463 | 0.88 | MMP2 (0.53) | MMP2MMP3MMP9MMP1MMP14 | |
| SCHEMBL6438592 | 0.86 | MMP2 (0.51) | MMP2MMP3MMP9MMP1MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1036062-B1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LTD (GB) | 2004-01-02 | — | — | EP | disclosed |
| US-6495568-B1 | TREATMENT OF TISSUE ULCERATION, WOUND REPAIR AND SKIN DISEASES | WARNER-LAMBERT COMPANY | 2002-12-17 | — | — | US | disclosed |